Reduced intensity allogeneic hematopoietic stem cell transplantion for MDS using tacrolimus/sirolimus-based GVHD prophylaxis

We report a consecutive series of 59 patients with MDS who underwent reduced-intensity hematopoietic stem cell transplantation (RI-HSCT) with fludarabine/melphalan conditioning and tacrolimus/sirolimus-based GVHD prophylaxis. Two-year OS, EFS, and relapse incidences were 75.1%, 65.2%, and 20.9%, res...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Nakamura, Ryotaro, Palmer, Joycelynne M., O'Donnell, Margaret R., Stiller, Tracey, Thomas, Sandra H., Chao, Joseph, Alvarnas, Joseph, Parker, Pablo M., Pullarkat, Vinod, Maegawa, Rodrigo, Stein, Anthony S., Snyder, David S., Bhatia, Ravi, Chang, Karen, Wang, Shirong, Cai, Ji-Lian, Senitzer, David, Forman, Stephen J.
Formato: Artigo
Idioma:Inglês
Publicado em: 2012
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3433241/
https://ncbi.nlm.nih.gov/pubmed/22677229
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.leukres.2012.04.022
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados